DD: Definium Therapeutics (DFTX) will go to $200
$DFTX
AI SUMMARY โ Definium Therapeutics (DFTX) is positioned for significant growth with promising drug pipeline and clinical developments that could drive the stock to $200. Key risks include clinical trial failures, regulatory challenges, and market competition in the pharmaceutical sector.
| TICKER | DFTX |
USER | u/buckwildboy |
| RATING |
BULLISH |
ENTRY |
$36.90
|
| POSITION |
271 sh
SYN
|
BOOK VAL |
$9998.55 |
| CURRENT |
$42.09 |
P&L % |
+14.08%
|
| CURR VAL |
$11406.39 |
P&L $ |
+1407.84
|